Baird Financial Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Sell |
28,871
-1,880
| -6% | -$4.14K | ﹤0.01% | 1755 |
|
|
2025
Q1 | $35.7K | Hold |
30,751
| – | – | ﹤0.01% | 1742 |
|
|
2024
Q4 | $39.1K | Sell |
30,751
-5,234
| -15% | -$6.65K | ﹤0.01% | 1739 |
|
|
2024
Q3 | $123K | Sell |
35,985
-477
| -1% | -$1.63K | ﹤0.01% | 1693 |
|
|
2024
Q2 | $170K | Buy |
36,462
+1,265
| +4% | +$5.91K | ﹤0.01% | 1694 |
|
|
2024
Q1 | $261K | Buy |
35,197
+6,002
| +21% | +$44.5K | ﹤0.01% | 1604 |
|
|
2023
Q4 | $296K | Buy |
29,195
+3,230
| +12% | +$32.7K | ﹤0.01% | 1522 |
|
|
2023
Q3 | $203K | Buy |
25,965
+686
| +3% | +$5.35K | ﹤0.01% | 1625 |
|
|
2023
Q2 | $208K | Buy |
25,279
+218
| +0.9% | +$1.79K | ﹤0.01% | 1607 |
|
|
2023
Q1 | $182K | Buy |
25,061
+7,904
| +46% | +$57.3K | ﹤0.01% | 1627 |
|
|
2022
Q4 | $152K | Buy |
17,157
+6,285
| +58% | +$55.7K | ﹤0.01% | 1628 |
|
|
2022
Q3 | $133K | Buy |
10,872
+374
| +4% | +$4.58K | ﹤0.01% | 1649 |
|
|
2022
Q2 | $125K | Sell |
10,498
-265
| -2% | -$3.16K | ﹤0.01% | 1734 |
|
|
2022
Q1 | $205K | Buy |
10,763
+800
| +8% | +$15.2K | ﹤0.01% | 1745 |
|
|
2021
Q4 | $265K | Buy |
+9,963
| New | +$265K | ﹤0.01% | 1723 |
|